Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00415298
Status:
UNKNOWN
Last Update Posted:
2014-01-10
First Post:
2006-12-20
Brief Title:
AP5346 or Oxaliplatin in Treating Patients With Metastatic andor Unresectable Recurrent Head and Neck Cancer
Sponsor:
University of California San Diego
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| recurrent squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| recurrent squamous cell carcinoma of the nasopharynx | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| stage III squamous cell carcinoma of the hypopharynx | View |
| stage III squamous cell carcinoma of the larynx | View |
| stage III squamous cell carcinoma of the lip and oral cavity | View |
| stage III squamous cell carcinoma of the nasopharynx | View |
| stage III squamous cell carcinoma of the oropharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the nasopharynx | View |
| stage IV squamous cell carcinoma of the oropharynx | View |